It is estimated that two billion euro’s a year is the size of the European market of CBD. Already, the plant extract is being added to cheeseburgers, toothpicks and breath sprays. The World Health Organisation reports “In humans, CBD exhibits no effects indicative of any abuse or dependence potential….To date, there is no evidence of public health problems associated the use of pure CBD”. Part of CBD’s popularity is that it purports to be “nonpsychoactive,” and that consumers can reap health benefits from the plant without the high (or the midnight pizza munchies). In today's episode we explore the facts and science surrounding the trendy CBD market. Dr Julie Moltke is a peer-reviewed clinical researcher and industry consultant with a focus on medicinal cannabis and holistic health. Dr Julie Moltke prescribes medicinal cannabis at Horsted Institute in Denmark and works in child psychiatry in Sweden. She is on the advisory board of The Conservative Drug Policy Reform Group, The Primary Care Cannabis Network, and the patient organisation CPASS, among others. Show Notes Host: @sarahannmacklin | www.sarahannmacklin.com Be Well Collective: @be_well_collective | www.bewellcollective.co.uk Guest: @julie.moltke www.drjuliemoltke.com |Author of "A Quick Guide to CBD" | FREE SAMPLE OF CBD with Columbia Care Add to your basket a 10ml Broad Spectrum CBD oil and use the code LBWBFREE at the checkout to get your FREE CBD sample! One per customer, available on www.shop.col-care.uk

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related